Navigation Links
Wilson Center awarded European Union grant for synthetic biology work
Date:11/18/2013

WASHINGTONThe Synthetic Biology Project at the Woodrow Wilson International Center for Scholars has been awarded a grant to participate in SYNENERGENE, a newly launched consortium of 28 groups supported with 4 million ($5.3 million) from the European Commission's Seventh Framework Programme to engage in the responsible governance of synthetic biology.

The Synthetic Biology Project is the only U.S. partner in the SYNENERGENE consortium. Over the next four years, the project seeks to foster responsible governance of synthetic biology by initiating mutual learning processes among a wide variety of stakeholders from science, industry, civil society, policy, education and art.

"The core value of SYNENERGENE is its emphasis on mutual learning between participants," says Eleonore Pauwels, a researcher with the Synthetic Biology Project. "Mutual learning requires the creation of a 'trading zone,' where knowledge can be shared, but no single voice dominates the dialogue and attention is given to expertise."

The Synthetic Biology Project will begin its work with a report identifying synergies between European and international synthetic biology actors around responsible research and innovation. The initiative will also support collaboration and open forums to promote a growing international community of practice focused on the policy aspects and governance of synthetic biology.

The overall initiative is being coordinated by the Karlsruhe Institute of Technology (KIT) in Germany. "Synthetic biology is an emerging field of science and technology, the contours of which are not yet clear," says Christopher Coenen of KIT's Institute for Technology Assessment and Systems Analysis. "We aim to involve citizens and a wide variety of stakeholders at an early stage in the process and to stimulate discussions between them."

Organizers hope the iterative mutual learning process wit
'/>"/>

Contact: Eleonore Pauwels
eleonore.pauwels@wilsoncenter.org
202-691-4359
Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program

Christopher Coenen
contact@synenergene.eu
49-721-608-24559
Karlsruhe Institute


Source:Eurekalert

Page: 1 2

Related biology news :

1. MIT and Wilson Center receive NSF grant to develop synthetic biology research agenda
2. Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation
3. NIH grant funds multi-center study of mysterious trauma-induced hemorrhaging
4. Cancer imaging centers get £35 million boost
5. Johns Hopkins And Belgian research center to expand health care applications for silicon nanotech
6. Vinyl flooring linked to potentially harmful substances at schools and daycare centers
7. Washington Eye Center is now Precision Eye Care
8. Medbox Partners with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
9. Family Resiliency Center helps study how food-bank clients afford basic non-food items
10. New York Genome Center announces the New York Stem Cell Foundation as an Associate Member
11. RIKEN and leading Indian institutions launch Joint Research Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik ... und findet vom 22. bis 25. Oktober 2015 ... Die Konferenz feiert in diesem ... ist die ICG weltweit zu einem der einflussreichsten ... eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4
... year since their 2008 preliminary ranking, Cell Press journals Cell ... their Impact Factors surge, according to new data released in the ... released June 17, Cell Stem Cell ,s rating rose to ... Cell Host and Microbe ranks 13.021 - boasting an ...
... Two researchers from the University of Santiago de Compostela ... antisocial behaviour. The results show that the principal goal ... leave home. The most antisocial among them place greater ... teenagers place most importance on are to do with ...
... currently being undertaken at the University of Leicester may ... Aneurysms (AAA) in men. In her doctoral study, ... causes of the male predominance of AAA, with a ... results from the study will be showcased at the ...
Cached Biology News:New 2009 Impact Factors soar for newest Cell Press journals 2Teenagers want to finish their studies and leave home 2Increased likelihood of male death from disease 2
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation ... largest providers of post-acute healthcare services, offering both ... results of operations for the second quarter ended ... was characterized by strong volume growth in both ... EBITDA," said Jay Grinney, President and Chief Executive ...
(Date:7/29/2015)... Research and Markets ... the "Global Biosimilars Market, 2015 - 2025" ... Global Biosimilars Market, 2015 - 2025, report provides ... market. With the blockbuster biologics losing patent protection ... are being viewed as viable substitutes to the ...
(Date:7/29/2015)... , July 29, 2015  Therapath Neuropathology ... announces increased partnerships with VA and Military Medical ... Nerve Fiber Density (ENFD) and Sweat Gland Nerve ... fiber neuropathy ( https://therapath.com/skin ). ... Fiber Density (ENFD) on punch skin biopsy is ...
(Date:7/29/2015)... ... ... The third Medical Innovation Impact Index (MI3) Alert considers FDA processes for ... current system received a score of 0 (range -10 to +10) for its impact ... Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation and Entrepreneurship. Several changes ...
Breaking Biology Technology:HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27HealthSouth Reports Results for Second Quarter 2015 28HealthSouth Reports Results for Second Quarter 2015 29HealthSouth Reports Results for Second Quarter 2015 30HealthSouth Reports Results for Second Quarter 2015 31HealthSouth Reports Results for Second Quarter 2015 32HealthSouth Reports Results for Second Quarter 2015 33HealthSouth Reports Results for Second Quarter 2015 34HealthSouth Reports Results for Second Quarter 2015 35HealthSouth Reports Results for Second Quarter 2015 36
... PXS, Nasdaq: PXSL) today announced that its Phase ... people with bronchiectasis has met its two,primary efficacy ... Data from the 362 subject study demonstrated a ... weeks of treatment with Bronchitol,as assessed by the ...
... ... - Company ... BioPharma, Inc.,(PDL) (Nasdaq: PDLI ) today announced a significant strategic ... antibodies in,oncology and select immunological diseases, following a months-long,business and portfolio ...
... - Plan Extends Financial Resources Beyond 2008 -, ... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... percent, and implementing a revised,operating plan that focuses ... programs while streamlining the company,s operations and extending,its ...
Cached Biology Technology:Phase III Trial Finds Pharmaxis' Bronchitol Effective 2Phase III Trial Finds Pharmaxis' Bronchitol Effective 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 4PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 5Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 2Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 3Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 4
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
Weinreb Linker...
Anti-Human Factor XIII HRPO (Polyclonal) (sheep IgG)...
Request Info...
Biology Products: